HEADER OXIDOREDUCTASE 28-JAN-21 7E0O
TITLE CRYSTAL STRUCTURE OF HUMAN INDOLEAMINE 2,3-DIOXYGENAGSE 1 (HIDO1)
TITLE 2 COMPLEXED WITH 6-BROMO-1H-INDAZOL-4-AMINE (1)
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: INDOLEAMINE 2,3-DIOXYGENASE 1;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: IDO-1,INDOLEAMINE-PYRROLE 2,3-DIOXYGENASE;
COMPND 5 EC: 1.13.11.52;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: IDO1, IDO, INDO;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008
KEYWDS INDOLEAMINE 2, 3-DIOXYGENASE 1, OXIDOREDUCTASE
EXPDTA X-RAY DIFFRACTION
AUTHOR G.-B.LI,X.-L.NING
REVDAT 3 23-OCT-24 7E0O 1 REMARK
REVDAT 2 29-NOV-23 7E0O 1 REMARK
REVDAT 1 21-JUL-21 7E0O 0
JRNL AUTH X.L.NING,Y.Z.LI,C.HUO,J.DENG,C.GAO,K.R.ZHU,M.WANG,Y.X.WU,
JRNL AUTH 2 J.L.YU,Y.L.REN,Z.Y.LUO,G.LI,Y.CHEN,S.Y.WANG,C.PENG,L.L.YANG,
JRNL AUTH 3 Z.Y.WANG,Y.WU,S.QIAN,G.B.LI
JRNL TITL X-RAY STRUCTURE-GUIDED DISCOVERY OF A POTENT, ORALLY
JRNL TITL 2 BIOAVAILABLE, DUAL HUMAN INDOLEAMINE/TRYPTOPHAN
JRNL TITL 3 2,3-DIOXYGENASE (HIDO/HTDO) INHIBITOR THAT SHOWS ACTIVITY IN
JRNL TITL 4 A MOUSE MODEL OF PARKINSON'S DISEASE.
JRNL REF J.MED.CHEM. V. 64 8303 2021
JRNL REFN ISSN 0022-2623
JRNL PMID 34110158
JRNL DOI 10.1021/ACS.JMEDCHEM.1C00303
REMARK 2
REMARK 2 RESOLUTION. 3.34 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX 1.10.1_2155
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : ML
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.34
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 65.49
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330
REMARK 3 COMPLETENESS FOR RANGE (%) : 96.3
REMARK 3 NUMBER OF REFLECTIONS : 15786
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.221
REMARK 3 R VALUE (WORKING SET) : 0.211
REMARK 3 FREE R VALUE : 0.302
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000
REMARK 3 FREE R VALUE TEST SET COUNT : 1578
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 65.4920 - 7.4173 0.99 1435 159 0.1796 0.2401
REMARK 3 2 7.4173 - 5.8885 1.00 1377 154 0.2056 0.2869
REMARK 3 3 5.8885 - 5.1445 1.00 1345 150 0.2009 0.2924
REMARK 3 4 5.1445 - 4.6743 0.99 1335 148 0.1757 0.2734
REMARK 3 5 4.6743 - 4.3393 1.00 1329 148 0.1938 0.2798
REMARK 3 6 4.3393 - 4.0835 0.99 1306 144 0.2002 0.3350
REMARK 3 7 4.0835 - 3.8791 0.99 1315 147 0.2178 0.3346
REMARK 3 8 3.8791 - 3.7102 1.00 1309 144 0.2530 0.3546
REMARK 3 9 3.7102 - 3.5674 0.99 1324 146 0.3249 0.5195
REMARK 3 10 3.5674 - 3.4443 0.89 1084 120 0.3080 0.4071
REMARK 3 11 3.4443 - 3.3370 0.96 1049 118 0.3357 0.3915
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.510
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 36.820
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 104.7
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.019 6139
REMARK 3 ANGLE : 1.703 8332
REMARK 3 CHIRALITY : 0.059 900
REMARK 3 PLANARITY : 0.010 1056
REMARK 3 DIHEDRAL : 18.412 3633
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 7E0O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 29-JAN-21.
REMARK 100 THE DEPOSITION ID IS D_1300020539.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 10-DEC-20
REMARK 200 TEMPERATURE (KELVIN) : 195
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SSRF
REMARK 200 BEAMLINE : BL19U1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 X CDTE 1M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROCESS
REMARK 200 DATA SCALING SOFTWARE : WEB-ICE
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15866
REMARK 200 RESOLUTION RANGE HIGH (A) : 3.337
REMARK 200 RESOLUTION RANGE LOW (A) : 71.652
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 96.8
REMARK 200 DATA REDUNDANCY : 13.37
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.2000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.34
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.39
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 5ETW
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 60.00
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.08
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 15% TO 23% PEG 8000, 0.2M AMMONIUM
REMARK 280 ACETATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 42.79700
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.49150
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.39650
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.49150
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 42.79700
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.39650
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLN A 361
REMARK 465 PRO A 362
REMARK 465 LYS A 363
REMARK 465 GLU A 364
REMARK 465 ASN A 365
REMARK 465 LYS A 366
REMARK 465 THR A 367
REMARK 465 SER A 368
REMARK 465 GLU A 369
REMARK 465 ASP A 370
REMARK 465 PRO A 371
REMARK 465 SER A 372
REMARK 465 LYS A 373
REMARK 465 LEU A 374
REMARK 465 GLU A 375
REMARK 465 ALA A 376
REMARK 465 LYS A 377
REMARK 465 GLY A 378
REMARK 465 THR A 379
REMARK 465 LYS A 401
REMARK 465 GLU A 402
REMARK 465 GLY A 403
REMARK 465 GLN B 361
REMARK 465 PRO B 362
REMARK 465 LYS B 363
REMARK 465 GLU B 364
REMARK 465 ASN B 365
REMARK 465 LYS B 366
REMARK 465 THR B 367
REMARK 465 SER B 368
REMARK 465 GLU B 369
REMARK 465 ASP B 370
REMARK 465 PRO B 371
REMARK 465 SER B 372
REMARK 465 LYS B 373
REMARK 465 LEU B 374
REMARK 465 GLU B 375
REMARK 465 ALA B 376
REMARK 465 LYS B 377
REMARK 465 GLY B 378
REMARK 465 THR B 379
REMARK 465 LYS B 401
REMARK 465 GLU B 402
REMARK 465 GLY B 403
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 LYS A 13 CG CD CE NZ
REMARK 470 LYS B 13 CG CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 OE2 GLU B 171 OG SER B 267 2.05
REMARK 500 OD1 ASP B 72 OG SER B 75 2.07
REMARK 500 NH2 ARG B 317 O SER B 398 2.07
REMARK 500 OE1 GLN B 29 OG SER B 75 2.09
REMARK 500 NH2 ARG A 80 OD2 ASP A 128 2.09
REMARK 500 O LEU B 342 N TYR B 345 2.13
REMARK 500 OD2 ASP B 274 NH2 ARG B 343 2.14
REMARK 500 N MET A 64 OD1 ASN A 106 2.17
REMARK 500 O SER B 268 N PHE B 270 2.18
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 ARG A 100 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES
REMARK 500 CYS A 129 CA - CB - SG ANGL. DEV. = 7.0 DEGREES
REMARK 500 CYS B 85 CA - CB - SG ANGL. DEV. = 9.0 DEGREES
REMARK 500 LEU B 201 CB - CG - CD1 ANGL. DEV. = -10.3 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 LYS A 13 -119.28 -54.12
REMARK 500 ASN A 27 73.34 57.69
REMARK 500 TYR A 36 46.33 -140.89
REMARK 500 TRP A 39 -73.35 -69.21
REMARK 500 ILE A 42 -75.20 -52.25
REMARK 500 ALA A 43 -37.45 -32.54
REMARK 500 SER A 52 10.14 -68.42
REMARK 500 ARG A 56 24.28 -78.43
REMARK 500 GLU A 60 -58.45 -15.28
REMARK 500 ASP A 68 -37.76 -24.91
REMARK 500 THR A 71 -76.51 -102.51
REMARK 500 HIS A 73 -70.19 -57.18
REMARK 500 PRO A 104 151.85 -48.00
REMARK 500 SER A 115 -72.31 -67.04
REMARK 500 LYS A 116 -8.91 -52.81
REMARK 500 GLU A 119 64.89 38.23
REMARK 500 PRO A 122 73.11 -69.00
REMARK 500 VAL A 130 -38.44 -134.18
REMARK 500 ASN A 133 64.21 -60.28
REMARK 500 PRO A 139 36.06 -79.00
REMARK 500 ASN A 140 -4.37 -140.98
REMARK 500 LEU A 143 88.75 -66.59
REMARK 500 CYS A 159 -7.36 82.03
REMARK 500 SER A 160 -23.48 -25.54
REMARK 500 GLU A 171 -27.61 -31.64
REMARK 500 GLN A 191 101.91 54.10
REMARK 500 GLU A 192 75.40 -157.25
REMARK 500 ALA A 210 -6.17 -50.19
REMARK 500 PHE A 214 -22.27 -28.99
REMARK 500 ILE A 217 -38.86 -39.80
REMARK 500 VAL A 229 -90.08 -80.23
REMARK 500 LEU A 230 -74.39 -37.24
REMARK 500 ARG A 231 -43.48 -23.23
REMARK 500 PHE A 252 -50.31 -148.63
REMARK 500 VAL A 269 -107.58 -68.19
REMARK 500 PHE A 270 -65.61 -1.89
REMARK 500 LEU A 277 23.14 -67.41
REMARK 500 PHE A 291 -90.79 -43.89
REMARK 500 LEU A 292 -20.70 -37.33
REMARK 500 PRO A 300 -165.05 -38.28
REMARK 500 LEU A 310 -71.19 -64.09
REMARK 500 SER A 315 107.03 -46.80
REMARK 500 ALA A 326 -13.49 -49.64
REMARK 500 ILE A 354 -34.01 -135.56
REMARK 500 THR A 382 -63.43 -22.73
REMARK 500 ASP A 383 -33.19 -35.74
REMARK 500 THR A 390 -30.53 -32.25
REMARK 500 LYS A 397 26.79 -63.23
REMARK 500 HIS B 16 71.26 74.67
REMARK 500 ASN B 27 52.93 32.92
REMARK 500
REMARK 500 THIS ENTRY HAS 89 RAMACHANDRAN OUTLIERS.
REMARK 500
REMARK 500 REMARK: NULL
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 HEM A 502 FE
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 HIS A 346 NE2
REMARK 620 2 HEM A 502 NA 104.8
REMARK 620 3 HEM A 502 NB 93.2 92.7
REMARK 620 4 HEM A 502 NC 83.1 171.0 82.4
REMARK 620 5 HEM A 502 ND 92.0 92.5 171.5 91.6
REMARK 620 6 HS0 A 501 N08 161.1 92.3 77.9 79.3 95.2
REMARK 620 N 1 2 3 4 5
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 HEM B 502 FE
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 HIS B 346 NE2
REMARK 620 2 HEM B 502 NA 80.1
REMARK 620 3 HEM B 502 NB 103.2 84.2
REMARK 620 4 HEM B 502 NC 109.7 168.9 88.2
REMARK 620 5 HEM B 502 ND 84.7 93.7 171.4 92.5
REMARK 620 6 HS0 B 501 N08 168.4 91.0 83.2 79.9 88.5
REMARK 620 N 1 2 3 4 5
DBREF 7E0O A 12 403 UNP P14902 I23O1_HUMAN 12 403
DBREF 7E0O B 12 403 UNP P14902 I23O1_HUMAN 12 403
SEQRES 1 A 392 SER LYS GLU TYR HIS ILE ASP GLU GLU VAL GLY PHE ALA
SEQRES 2 A 392 LEU PRO ASN PRO GLN GLU ASN LEU PRO ASP PHE TYR ASN
SEQRES 3 A 392 ASP TRP MET PHE ILE ALA LYS HIS LEU PRO ASP LEU ILE
SEQRES 4 A 392 GLU SER GLY GLN LEU ARG GLU ARG VAL GLU LYS LEU ASN
SEQRES 5 A 392 MET LEU SER ILE ASP HIS LEU THR ASP HIS LYS SER GLN
SEQRES 6 A 392 ARG LEU ALA ARG LEU VAL LEU GLY CYS ILE THR MET ALA
SEQRES 7 A 392 TYR VAL TRP GLY LYS GLY HIS GLY ASP VAL ARG LYS VAL
SEQRES 8 A 392 LEU PRO ARG ASN ILE ALA VAL PRO TYR CYS GLN LEU SER
SEQRES 9 A 392 LYS LYS LEU GLU LEU PRO PRO ILE LEU VAL TYR ALA ASP
SEQRES 10 A 392 CYS VAL LEU ALA ASN TRP LYS LYS LYS ASP PRO ASN LYS
SEQRES 11 A 392 PRO LEU THR TYR GLU ASN MET ASP VAL LEU PHE SER PHE
SEQRES 12 A 392 ARG ASP GLY ASP CYS SER LYS GLY PHE PHE LEU VAL SER
SEQRES 13 A 392 LEU LEU VAL GLU ILE ALA ALA ALA SER ALA ILE LYS VAL
SEQRES 14 A 392 ILE PRO THR VAL PHE LYS ALA MET GLN MET GLN GLU ARG
SEQRES 15 A 392 ASP THR LEU LEU LYS ALA LEU LEU GLU ILE ALA SER CYS
SEQRES 16 A 392 LEU GLU LYS ALA LEU GLN VAL PHE HIS GLN ILE HIS ASP
SEQRES 17 A 392 HIS VAL ASN PRO LYS ALA PHE PHE SER VAL LEU ARG ILE
SEQRES 18 A 392 TYR LEU SER GLY TRP LYS GLY ASN PRO GLN LEU SER ASP
SEQRES 19 A 392 GLY LEU VAL TYR GLU GLY PHE TRP GLU ASP PRO LYS GLU
SEQRES 20 A 392 PHE ALA GLY GLY SER ALA GLY GLN SER SER VAL PHE GLN
SEQRES 21 A 392 CYS PHE ASP VAL LEU LEU GLY ILE GLN GLN THR ALA GLY
SEQRES 22 A 392 GLY GLY HIS ALA ALA GLN PHE LEU GLN ASP MET ARG ARG
SEQRES 23 A 392 TYR MET PRO PRO ALA HIS ARG ASN PHE LEU CYS SER LEU
SEQRES 24 A 392 GLU SER ASN PRO SER VAL ARG GLU PHE VAL LEU SER LYS
SEQRES 25 A 392 GLY ASP ALA GLY LEU ARG GLU ALA TYR ASP ALA CYS VAL
SEQRES 26 A 392 LYS ALA LEU VAL SER LEU ARG SER TYR HIS LEU GLN ILE
SEQRES 27 A 392 VAL THR LYS TYR ILE LEU ILE PRO ALA SER GLN GLN PRO
SEQRES 28 A 392 LYS GLU ASN LYS THR SER GLU ASP PRO SER LYS LEU GLU
SEQRES 29 A 392 ALA LYS GLY THR GLY GLY THR ASP LEU MET ASN PHE LEU
SEQRES 30 A 392 LYS THR VAL ARG SER THR THR GLU LYS SER LEU LEU LYS
SEQRES 31 A 392 GLU GLY
SEQRES 1 B 392 SER LYS GLU TYR HIS ILE ASP GLU GLU VAL GLY PHE ALA
SEQRES 2 B 392 LEU PRO ASN PRO GLN GLU ASN LEU PRO ASP PHE TYR ASN
SEQRES 3 B 392 ASP TRP MET PHE ILE ALA LYS HIS LEU PRO ASP LEU ILE
SEQRES 4 B 392 GLU SER GLY GLN LEU ARG GLU ARG VAL GLU LYS LEU ASN
SEQRES 5 B 392 MET LEU SER ILE ASP HIS LEU THR ASP HIS LYS SER GLN
SEQRES 6 B 392 ARG LEU ALA ARG LEU VAL LEU GLY CYS ILE THR MET ALA
SEQRES 7 B 392 TYR VAL TRP GLY LYS GLY HIS GLY ASP VAL ARG LYS VAL
SEQRES 8 B 392 LEU PRO ARG ASN ILE ALA VAL PRO TYR CYS GLN LEU SER
SEQRES 9 B 392 LYS LYS LEU GLU LEU PRO PRO ILE LEU VAL TYR ALA ASP
SEQRES 10 B 392 CYS VAL LEU ALA ASN TRP LYS LYS LYS ASP PRO ASN LYS
SEQRES 11 B 392 PRO LEU THR TYR GLU ASN MET ASP VAL LEU PHE SER PHE
SEQRES 12 B 392 ARG ASP GLY ASP CYS SER LYS GLY PHE PHE LEU VAL SER
SEQRES 13 B 392 LEU LEU VAL GLU ILE ALA ALA ALA SER ALA ILE LYS VAL
SEQRES 14 B 392 ILE PRO THR VAL PHE LYS ALA MET GLN MET GLN GLU ARG
SEQRES 15 B 392 ASP THR LEU LEU LYS ALA LEU LEU GLU ILE ALA SER CYS
SEQRES 16 B 392 LEU GLU LYS ALA LEU GLN VAL PHE HIS GLN ILE HIS ASP
SEQRES 17 B 392 HIS VAL ASN PRO LYS ALA PHE PHE SER VAL LEU ARG ILE
SEQRES 18 B 392 TYR LEU SER GLY TRP LYS GLY ASN PRO GLN LEU SER ASP
SEQRES 19 B 392 GLY LEU VAL TYR GLU GLY PHE TRP GLU ASP PRO LYS GLU
SEQRES 20 B 392 PHE ALA GLY GLY SER ALA GLY GLN SER SER VAL PHE GLN
SEQRES 21 B 392 CYS PHE ASP VAL LEU LEU GLY ILE GLN GLN THR ALA GLY
SEQRES 22 B 392 GLY GLY HIS ALA ALA GLN PHE LEU GLN ASP MET ARG ARG
SEQRES 23 B 392 TYR MET PRO PRO ALA HIS ARG ASN PHE LEU CYS SER LEU
SEQRES 24 B 392 GLU SER ASN PRO SER VAL ARG GLU PHE VAL LEU SER LYS
SEQRES 25 B 392 GLY ASP ALA GLY LEU ARG GLU ALA TYR ASP ALA CYS VAL
SEQRES 26 B 392 LYS ALA LEU VAL SER LEU ARG SER TYR HIS LEU GLN ILE
SEQRES 27 B 392 VAL THR LYS TYR ILE LEU ILE PRO ALA SER GLN GLN PRO
SEQRES 28 B 392 LYS GLU ASN LYS THR SER GLU ASP PRO SER LYS LEU GLU
SEQRES 29 B 392 ALA LYS GLY THR GLY GLY THR ASP LEU MET ASN PHE LEU
SEQRES 30 B 392 LYS THR VAL ARG SER THR THR GLU LYS SER LEU LEU LYS
SEQRES 31 B 392 GLU GLY
HET HS0 A 501 11
HET HEM A 502 43
HET HS0 B 501 11
HET HEM B 502 43
HETNAM HS0 6-BROMANYL-1~{H}-INDAZOL-4-AMINE
HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE
HETSYN HEM HEME
FORMUL 3 HS0 2(C7 H6 BR N3)
FORMUL 4 HEM 2(C34 H32 FE N4 O4)
HELIX 1 AA1 PRO A 33 PHE A 35 5 3
HELIX 2 AA2 TYR A 36 HIS A 45 1 10
HELIX 3 AA3 HIS A 45 SER A 52 1 8
HELIX 4 AA4 GLN A 54 VAL A 59 1 6
HELIX 5 AA5 SER A 66 LEU A 70 5 5
HELIX 6 AA6 ASP A 72 GLY A 93 1 22
HELIX 7 AA7 VAL A 109 LEU A 118 1 10
HELIX 8 AA8 VAL A 125 VAL A 130 1 6
HELIX 9 AA9 CYS A 159 SER A 176 1 18
HELIX 10 AB1 VAL A 180 GLN A 191 1 12
HELIX 11 AB2 GLU A 192 GLU A 208 1 17
HELIX 12 AB3 LYS A 209 HIS A 215 1 7
HELIX 13 AB4 GLN A 216 VAL A 221 1 6
HELIX 14 AB5 ASN A 222 VAL A 229 1 8
HELIX 15 AB6 VAL A 229 SER A 235 1 7
HELIX 16 AB7 SER A 263 GLN A 266 5 4
HELIX 17 AB8 SER A 267 LEU A 277 1 11
HELIX 18 AB9 GLY A 286 MET A 295 1 10
HELIX 19 AC1 HIS A 303 SER A 312 1 10
HELIX 20 AC2 ARG A 317 GLY A 324 1 8
HELIX 21 AC3 ASP A 325 ILE A 354 1 30
HELIX 22 AC4 ILE A 354 SER A 359 1 6
HELIX 23 AC5 GLY A 381 LYS A 397 1 17
HELIX 24 AC6 TYR B 36 HIS B 45 1 10
HELIX 25 AC7 HIS B 45 GLY B 53 1 9
HELIX 26 AC8 GLN B 54 LYS B 61 1 8
HELIX 27 AC9 SER B 66 LEU B 70 5 5
HELIX 28 AD1 ASP B 72 GLY B 93 1 22
HELIX 29 AD2 PRO B 104 GLU B 119 1 16
HELIX 30 AD3 VAL B 125 VAL B 130 1 6
HELIX 31 AD4 CYS B 159 ILE B 172 1 14
HELIX 32 AD5 VAL B 180 MET B 190 1 11
HELIX 33 AD6 GLU B 192 PHE B 214 1 23
HELIX 34 AD7 HIS B 215 HIS B 220 5 6
HELIX 35 AD8 ASN B 222 VAL B 229 1 8
HELIX 36 AD9 VAL B 229 SER B 235 1 7
HELIX 37 AE1 SER B 263 SER B 267 5 5
HELIX 38 AE2 VAL B 269 LEU B 277 1 9
HELIX 39 AE3 GLY B 286 MET B 295 1 10
HELIX 40 AE4 PRO B 300 SER B 312 1 13
HELIX 41 AE5 VAL B 316 LYS B 323 1 8
HELIX 42 AE6 GLY B 327 ILE B 354 1 28
HELIX 43 AE7 ILE B 356 GLN B 360 5 5
HELIX 44 AE8 THR B 382 LYS B 397 1 16
SHEET 1 AA1 3 VAL A 102 LEU A 103 0
SHEET 2 AA1 3 LEU A 247 TYR A 249 1 O VAL A 248 N LEU A 103
SHEET 3 AA1 3 TRP A 253 LYS A 257 -1 O TRP A 253 N TYR A 249
SHEET 1 AA2 2 LYS A 135 LYS A 136 0
SHEET 2 AA2 2 MET A 148 ASP A 149 -1 O ASP A 149 N LYS A 135
SHEET 1 AA3 2 VAL B 102 LEU B 103 0
SHEET 2 AA3 2 VAL B 248 TYR B 249 1 O VAL B 248 N LEU B 103
SHEET 1 AA4 2 TRP B 134 LYS B 136 0
SHEET 2 AA4 2 MET B 148 VAL B 150 -1 O ASP B 149 N LYS B 135
SSBOND 1 CYS A 308 CYS B 308 1555 1555 2.02
LINK NE2 HIS A 346 FE HEM A 502 1555 1555 1.76
LINK N08 HS0 A 501 FE HEM A 502 1555 1555 2.12
LINK NE2 HIS B 346 FE HEM B 502 1555 1555 1.85
LINK N08 HS0 B 501 FE HEM B 502 1555 1555 2.15
CRYST1 85.594 96.793 130.983 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.011683 0.000000 0.000000 0.00000
SCALE2 0.000000 0.010331 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007635 0.00000